Regarding the antiviral capacity of the NOD1 pathway in the context of viral infections, previous results demonstrated that NOD1 agonist DAP inhibits viral replication of HBV in pretreated C57BL/w mice by decreasing HB antigen and DNA levels due to enhanced T cell activation and immune response [31]. The gene discussed is GSTM1; the disease is viral infectious disease.